secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001437749-25-034997
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q3 revenue falls 28% to $1.55M; net loss widens; raises $3.1M via warrant exercise
--------------------------------------------------------------------------------

- Q3 2025 revenue $1.55M (down 28% YoY); net loss ($964,849) or ($0.15) per share vs ($738,959) ($0.39) in Q3'24.
- Full year 2025 revenue guidance $6.5-$7M.
- On Oct 27, raised $3.1M gross via warrant exercise at $1.02/share (3.09M shares); used proceeds to prepay notes.
- Launched EcoID III scanner; secured Middle East defense biometric deployment.
- Balance sheet: $2.0M cash at Sep 30 vs $0.4M at Dec 31; total notes outstanding $675k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925034997/0001437749-25-034997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925034997/bkyi20251113_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-034997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer